Director Rajeev Shah resigns; C. Daniel Myers appointed to board

KALA BIO, Inc.

Rajeev Shah resigned effective Oct 15, 2021; no disagreement with company on operations.
C. Daniel Myers appointed as Class III director, term expiring at 2023 annual meeting.
Myers is CEO of MediPrint Ophthalmics, former CEO and co-founder of Alimera Sciences.
Myers received option to purchase 42,000 shares at $2.21, vesting over three years.
Myers also appointed to Compensation Committee and Nominating and Corporate Governance Committee.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Rajeev Shah

member of the Board of Directors

KALA · KALA BIO, Inc.

Effective: 2021-10-15
Successor: C. Daniel Myers
Filed: October 18, 2021, 7:59 PM ET

On October 14, 2021, Rajeev Shah notified Kala Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”), which resignation was effective on October 15, 2021.

Appointed

C. Daniel Myers

member of the Board of Directors

KALA · KALA BIO, Inc.

Effective: 2021-10-15
Filed: October 18, 2021, 7:59 PM ET

On October 15, 2021, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed C. Daniel Myers as a member of the Board, effective immediately, to fill the vacancy created by the resignation of Mr. Shah.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Rajeev Shah resigned as member of the Board of Directors at KALA BIO, Inc..

Action: resigned
Role: member of the Board of Directors

Exact text from the filing

On October 14, 2021, Rajeev Shah notified Kala Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company (the “Board”), which resignation was effective on October 15, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

C. Daniel Myers was appointed as member of the Board of Directors at KALA BIO, Inc..

Action: appointed
Role: member of the Board of Directors

Exact text from the filing

On October 15, 2021, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed C. Daniel Myers as a member of the Board, effective immediately, to fill the vacancy created by the resignation of Mr. Shah.

View on SEC.gov

KALA BIO, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-21-013248

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.